祛湿通络方联合秋水仙碱片治疗急性痛风性关节炎湿热蕴结证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R589.7

基金项目:


Clinical Study on Qushi Tongluo Prescription Combined with Colchicine Tablets for Acute Gouty Arthritis with Dampness-Heat Accumulation Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察祛湿通络方联合秋水仙碱片治疗急性痛风性关节炎(AGA)的疗效。方法:选择 90 例 AGA 湿热蕴结证患者,采用随机数字表法分为对照组及观察组,每组 45 例。2 组均口服别嘌醇片,对照组在此基础上口服常规剂量秋水仙碱片,观察组口服小剂量秋水仙碱片联合祛湿通络方,2 组均治疗 8 周。比较 2 组治疗前后关节疼痛、关节功能评分,检测血尿酸(BUA) 及血清白细胞介素-1β (IL-1β)、肿瘤坏死因子-α (TNF-α) 水平,评价临床疗效,记录不良反应发生情况。结果:观察组总有效率为 88.9%,对照组总有效率为 66.7%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组关节疼痛分评分、节功能评分、血清 IL-1β、TNF-α水平均较治疗前降低 (P<0.05,P<0.01);观察组关节疼痛评分、关节功能评分均低于对照组 (P<0.01),2 组血清 IL-1β、TNF-α比较,差异均无统计学意义 (P>0.05)。治疗 4 周、8 周,2 组 BUA 水平均较治疗前降低(P<0.05);观察组 BUA 水平低于对照组(P<0.05)。治疗期间,不良反应发生率观察组为 26.7%,对照组为 46.7%,2 组比较,差异有统计学意义 (P<0.05)。结论:祛湿通络方联合小剂量秋水仙碱片可有效降低 AGA 湿热蕴结证患者 BUA、IL-1β、TNF-α水平,改善其关节功能,减少药物不良反应。

    Abstract:

    Abstract:Objective:To observe the curative effect of Qushi Tongluo prescription combined with colchicine tablets for acute gouty arthritis(AGA). Methods:A total of 90 cases of AGA patients with dampness-heat accumulation syndrome were selected and divided into two groups according to the random number table method,45 cases in each group. Both groups were given oral administration of allopurinol tablets; the control group was additionally given routine dose of colchicine tablets;the observation group was additionally given oral administration of low-dose colchicine tablets combined with Qushi Tongluo prescription. Both groups were treated for eight weeks. Before and after treatment,the scores of joint pain and joint function in the two groups were compared; the levels of blood uric acid(BUA), serum interleukin- 1β(IL- 1β) and tumor necrosis factor- α(TNF- α) were detected. The clinical effect was evaluated and the incidence of adverse reactions was recorded. Results: The total effective rate was 88.9% in the observation group and 66.7% in the control group, the difference being significant(P<0.05). After treatment,the scores of joint pain and joint function as well as the levels of IL-1β and TNF-α in serum in the two groups were decreased when compared with those before treatment(P<0.05,P<0.01);the scores of joint pain and joint function in the observation group were lower than those in the control group(P<0.01),and there was no significant difference being found in the comparison of IL-1β and TNF-α in serum in the two groups(P>0.05). After treatment for four weeks and eight weeks respectively,BUA levels in the two groups were decreased when compared with those before treatment(P<0.05);BUA levels in the observation group were lower than those in the control group(P<0.05). During treatment,the incidence of adverse reactions was 26.7% in the observation group and 46.7% in the control group, the difference being significant(P<0.05). Conclusion: Qushi Tongluo prescription combined with colchicine tablets can effectively reduce the levels of BUA, IL- 1β and TNF- α in plasmain AGA patients with dampness- heat accumulation syndrome, improve their joint function, enhance the curative effect and meanwhile reduce the adverse reactions of the drugs.

    参考文献
    相似文献
    引证文献
引用本文

史柯.祛湿通络方联合秋水仙碱片治疗急性痛风性关节炎湿热蕴结证临床研究[J].新中医,2020,52(22):83-86

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-11-27
  • 出版日期:
文章二维码